EnquBio is a US-based drug R&D technology and services provider that supports biotech and pharmaceutical partners from early discovery through translational research. Our partners benefit from our combined expertise and technology, fast turn-around-time, value, quality, and depth of our partnerships. Our services span Discovery Biology (target validation, cell line generation, iPSC platform, genome editing and functional assays), In Vitro Pharmacology (assay development, HTS & SAR screening, compound management), Immunology (T/B/dendritic cells, macrophages and monocytes, co-culture assays, whole blood, PBMCs), Biomarker Discovery (clinical sample analysis, flow cytometry, Western Blot (Jess), MSD, qRT-PCR), In Vivo Pharmacology (Efficacy studies in Oncology, Immuno-Oncology, Inflammation/Autoimmune and Metabolic Diseases, as well as PK/PD, safety/toxicity/biodistribution), and more. All studies are conducted in our state-of-the-art facility located in the heart of San Deigo’s biotech hub.